SEK275.00
2.07% today
Stockholm, Apr 04, 05:29 pm CET
ISIN
SE0000872095
Symbol
SOBI
Sector
Industry

Swedish Orphan Biovitrum Stock price

SEK275.00
-43.40 13.63% 1M
-28.60 9.42% 6M
-42.40 13.36% YTD
+13.60 5.20% 1Y
+45.00 19.57% 3Y
+101.90 58.87% 5Y
+184.00 202.20% 10Y
Stockholm, Closing price Fri, Apr 04 2025
-5.80 2.07%
ISIN
SE0000872095
Symbol
SOBI
Sector
Industry

Key metrics

Market capitalization SEK96.44b
Enterprise Value SEK112.04b
P/E (TTM) P/E ratio 24.74
EV/FCF (TTM) EV/FCF 15.52
EV/Sales (TTM) EV/Sales 4.30
P/S ratio (TTM) P/S ratio 3.71
P/B ratio (TTM) P/B ratio 2.39
Revenue growth (TTM) Revenue growth 17.65%
Revenue (TTM) Revenue SEK26.03b
EBIT (operating result TTM) EBIT SEK5.83b
Free Cash Flow (TTM) Free Cash Flow SEK7.22b
Cash position SEK1.14b
EPS (TTM) EPS SEK11.35
P/E forward 19.86
P/S forward 3.37
EV/Sales forward 3.92
Show more

Is Swedish Orphan Biovitrum a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Swedish Orphan Biovitrum Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Swedish Orphan Biovitrum forecast:

10x Buy
71%
3x Hold
21%
1x Sell
7%

Analyst Opinions

14 Analysts have issued a Swedish Orphan Biovitrum forecast:

Buy
71%
Hold
21%
Sell
7%

Financial data from Swedish Orphan Biovitrum

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
26,028 26,028
18% 18%
100%
- Direct Costs 9,233 9,233
14% 14%
35%
16,795 16,795
20% 20%
65%
- Selling and Administrative Expenses 3,755 3,755
4% 4%
14%
- Research and Development Expense 3,529 3,529
30% 30%
14%
9,511 9,511
28% 28%
37%
- Depreciation and Amortization 3,680 3,680
14% 14%
14%
EBIT (Operating Income) EBIT 5,831 5,831
40% 40%
22%
Net Profit 3,885 3,885
61% 61%
15%

In millions SEK.

Don't miss a Thing! We will send you all news about Swedish Orphan Biovitrum directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Swedish Orphan Biovitrum AB engages in the research, development, manufacture, and sale of pharmaceutical. The firm focuses on the hematology and immunology therapeutic areas. It also offers specialty treatments in the area of genetics and metabolism. The company was founded in 2001 and is headquartered in Solna, Sweden.

Head office Sweden
CEO Guido Oelkers
Employees 1,840
Founded 2001
Website www.sobi.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today